Efficacy and safety of clopidogrel only vs. clopidogrel added proton pump inhibitors in the treatment of patients with coronary heart disease after percutaneous coronary intervention

Efficacy and safety of clopidogrel only vs. clopidogrel added proton pump inhibitors in the treatment of patients with coronary heart disease after percutaneous coronary intervention

Background: Controversy still exists that whether clopidogrel should add proton pump inhibitors (PPIs) in patients with coronary heart disease after percutaneous coronary intervention (PCI). The aim of this study was to evaluate the efficacy and safety of clopidogrel added proton pump inhibitors (PP...

Full description

Bibliographic Details
Main Authors:	Jun Pang, Qiang Wu, Zheng Zhang, Tong-zhang Zheng, Qiuling Xiang, Ping Zhang, Xiaoqiao Liu, Changhai Zhang, Hongwen Tan, Jing Huang, Wei Liu, Fang Song, Zongzhuang Li, Feng Yue, Zhi Jiang, Fang Wei, Kai Zhou, Feng Tang, Yongyao Yang, Xiangshu Long, Chunyan Kuang, Yueting Wu, Baolin Chen, Ye Tian
Format:	Article
Language:	English
Published:	Elsevier 2019-06-01
Series:	International Journal of Cardiology: Heart & Vasculature
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352906718301866

Similar Items

Comparison of Ticagrelor and Clopidogrel for Patients Undergoing Emergency Percutaneous Coronary Intervention
by: Bin YANG, et al.
Published: (2018-07-01)

Clopidogrel and percutaneous coronary interventions.
by: Choudhury, R
Published: (2003)

Clopidogrel and percutaneous coronary interventions.
by: Bridges, J
Published: (2003)

Optimal strategy of switching from clopidogrel to ticagrelor in Chinese acute coronary syndrome patients with complicated coronary artery disease: the switching from clopidogrel to ticagrelor (SHIFT-CACS) study
by: Ying Yao, et al.
Published: (2019-10-01)

The role of clopidogrel in the current treatment of acute coronary syndrome
by: I. S. Yavelov
Published: (2020-06-01)

Determinants to optimize response to clopidogrel in acute coronary syndrome
by: Betti Giusti, et al.
Published: (2010-04-01)

Ticagrelor vs. Clopidogrel After Complex Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease
by: Ziwei Xi, et al.
Published: (2021-11-01)

Clopidogrel therapy effects on cell hemostasis in acute coronary syndrome
by: R. A. Rakhimova, et al.
Published: (2008-12-01)

Aspirin and clopidogrel hyporesponsiveness and nonresponsiveness in patients with coronary artery stenting
by: Rakesh K Sharma, et al.
Published: (2009-11-01)

Comparison of Efficacy between Clopidogrel and Ticagrelor in Patients with Acute Coronary Syndrome after Interventional Treatment and Their Effects on IL-6
by: Bin YANG, et al.
Published: (2020-02-01)

Effect of carboxylesterase 1 S75N on clopidogrel therapy among acute coronary syndrome patients
by: Fei-Yan Xiao, et al.
Published: (2017-08-01)

Validating the Prognostic Utility of the ABCD-GENE Score in Asian Patients with Acute Coronary Syndrome Patients on Clopidogrel
by: Cheng Keat Tan, et al.
Published: (2023-10-01)

Dual Antiplatelet Therapy with Clopidogrel and Aspirin Versus Aspirin Monotherapy in Patients Undergoing Coronary Artery Bypass Graft Surgery
by: Jianyu Qu, et al.
Published: (2021-06-01)

The clopidogrel after surgery for coronary artery disease (CASCADE) randomized controlled trial: clopidogrel and aspirin versus aspirin alone after coronary bypass surgery [NCT00228423]
by: Mesana Thierry G, et al.
Published: (2005-10-01)

P2Y12 Inhibitor Monotherapy with Clopidogrel versus Ticagrelor in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
by: Po-Wei Chen, et al.
Published: (2020-06-01)

Clopidogrel response in acute coronary syndrome : clinical implications & emerging therapies /
by: Miguel Castro, Antonio de
Published: (2011)

Clopidogrel: A Pharmacogenomic Perspective on its Use in Coronary Artery Disease
by: Chris Terpening
Published: (2010-12-01)

Clopidogrel: A Pharmacogenomic Perspective on its Use in Coronary Artery Disease
by: Chris Terpening
Published: (2010-01-01)

Use of clopidogrel in the reduction of myocardial damage during percutaneous coronary intervention
by: Arijit Dasgupta, et al.
Published: (2009-03-01)

Comparison of ticagrelor with clopidogrel on quality of life in patients with acute coronary syndrome
by: Hyeyeon Moon, et al.
Published: (2021-10-01)

Compared efficacy of clopidogrel and ticagrelor in treating acute coronary syndrome: a meta-analysis
by: Dong Wang, et al.
Published: (2018-11-01)

CLOPIDOGREL PHARMACOGENETICS
by: A. N. Meshkov
Published: (2016-01-01)

Cost-Effectiveness Comparison between Ticagrelor and Clopidogrel in Acute Coronary Syndrome in Iran
by: Amir Hashemi-meshkini, et al.
Published: (2023-04-01)

In-stent thrombosis when switching ticagrelor to clopidogrel after percutaneous coronary intervention
by: Aaron E. Brice, et al.
Published: (2017-04-01)

Pharmacodynamics and clinical effectiveness of clopidogrel and atorvastin in patients with acute coronary syndrome and hyperlipidaemia
by: A. S. Sivkov, et al.
Published: (2009-08-01)

Current views on antiplatelet therapy in acute coronary syndrome patients: the place of clopidogrel
by: O. O. Shakhmatova
Published: (2022-06-01)

Cost-effectiveness of ticagrelor and generic clopidogrel in patients with acute coronary syndrome in Switzerland
by: David Gasche, et al.
Published: (2013-09-01)

Cost-effectiveness of ticagrelor versus clopidogrel in patients with acute coronary syndromes in Canada
by: Grima DT, et al.
Published: (2014-01-01)

The effect of antiplatelet drug on coronary endothelial and microvascular function: comparison with ticagrelor and clopidogrel
by: Woong Gil Choi, et al.
Published: (2021-03-01)

Effect of Ticagrelor Versus Clopidogrel on Aortic Stiffness in Patients With Coronary Artery Disease
by: Charalambos Vlachopoulos, et al.
Published: (2019-06-01)

Comparison of clopidogrel and ticagrelor in treating acute coronary syndrome undergoing PCI: A systematic review and meta-analysis
by: Jing Yang, et al.
Published: (2024-03-01)

Association of ABCC2 polymorphism with clopidogrel response in Chinese patients undergoing percutaneous coronary intervention
by: Lida Chen, et al.
Published: (2022-10-01)

Comparisons between ticagrelor and clopidogrel following percutaneous coronary intervention in patients with acute coronary syndrome: a comprehensive meta-analysis
by: Fan ZG, et al.
Published: (2019-02-01)

Variants in clopidogrel-relevant genes and early neurological deterioration in ischemic stroke patients receiving clopidogrel
by: Xingyang Yi, et al.
Published: (2020-04-01)

The effect of doubling the dose of clopidogrel on platelet aggregation in patients with clopidogrel resistance
by: John I. Louca, et al.
Published: (2014-09-01)

Ticagrelor vs. clopidogrel for coronary microvascular dysfunction in patients with STEMI: a meta-analysis of randomized controlled trials
by: Yike Li, et al.
Published: (2023-05-01)

Ticagrelor versus clopidogrel in East Asian patients with acute coronary syndrome: A meta-analysis
by: He Meijiao, et al.
Published: (2022-02-01)

ABCB1 C3435T polymorphism and response to clopidogrel treatment in coronary artery disease (CAD) patients: a meta-analysis.
by: Jia Su, et al.
Published: (2012-01-01)

Efficacy and safety of switching from ticagrelor to clopidogrel during the early and late phase in acute coronary syndrome patients after percutaneous coronary intervention
by: Chenggang Wang, et al.
Published: (2020-04-01)

EFFECTS OF ACETYLSALICYLIC ACID AND CLOPIDOGREL ON MORPHOFUNCTIONAL STATUS OF ERYTHROCYTES IN PATIENTS WITH ACUTE CORONARY SYNDROME
by: A. L. Alyavi, et al.
Published: (2016-01-01)